Posted On: Friday, January 24th, 2014
Original posted on CATIE. Top 10 HIV and Hep C Research News from 2013 What were the most notable HIV and hepatitis C research stories from 2013? We’ve listed the top 10 stories from CATIE News below. 1. New evidence-based approaches to HIV and hepatitis C From national guidelines for HIV testing to best… Read more »
Posted On: Wednesday, January 8th, 2014
Continue Reading, CLICK HERE
Posted On: Wednesday, January 8th, 2014
Dec 23, 2013 03:06 pm | Deb Schmitz Recent comments by Liberal MP Gerry Byrne regarding Pamela Anderson show the depth of stigma and misinformation about hepatitis C that still exists in Canada today. President of Pacific Hepatitis C Network and hepatitis C survivor Daryl Luster states, “Stigma related to hepatitis C, and the… Read more »
Posted On: Wednesday, December 18th, 2013
February 26 – 28, 2014, Richmond, BC Registration Deadline: Friday, January 24th @4:00pm The Pacific AIDS Network (PAN) is excited to announce that we will be hosting a two and a half day conference for PAN member organizations and other allied/partner organizations, where frontline prevention, education, harm reduction, health promotion workers and program managers and… Read more »
Posted On: Thursday, December 12th, 2013
Continue Reading!
Posted On: Wednesday, December 11th, 2013
Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:”Table Normal”; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:””; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:”Times New Roman”,”serif”;} New and Noteworthy New study estimates cases of hepatitis B and C, but experts warn figures may be too low A new federal government… Read more »
Posted On: Thursday, November 14th, 2013
New and Noteworthy FDA advisory committee recommends the approval of simeprevir and sofosbuvir The Antiviral Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) unanimously recommended the approval of two direct-acting antivirals for hepatitis C, simeprevir and sofosbuvir. The newer direct-acting antiviral medications are more effective, easier to take and have significantly fewer… Read more »
Posted On: Thursday, November 7th, 2013
Click to read the document!
Posted On: Wednesday, November 6th, 2013
Continue reading
Posted On: Wednesday, November 6th, 2013
The Pacific Hepatitis C Network will be holding its Annual General Meeting on December 9, 2013 in Vancouver from 6 -8 pm. We will be announcing the location soon. This is a great opportunity to get together with other members of the Pacific Hepatitis C Network to share ideas, gain knowledge, and give input…. Read more »
Posted On: Thursday, October 10th, 2013
This is an exciting time in the evolution of HCV treatment in Canada. New approved treatment in the near future will offer patients the opportunity to achieve the highest SVR and cure. The hope is that the new drug Sofosbuvir will meet many current unmet needs and provide patients with the confidence to seek treatment… Read more »
Posted On: Wednesday, September 25th, 2013
HepCBC’s Cheryl Reitz recently attended and presented at the CATIE Fall Educational Conference in Toronto. Cheryl shared the entire presentation with the HepCBC network where she addresses the need for HCV testing in Baby Boomers. Read her speech, HERE
